Alucent Biomedical
Salt Lake City
About Alucent Biomedical
Alucent Biomedical is a biomedical company that develops a combination drug-device therapy called Natural Vascular Scaffolding (NVS) for the treatment of vascular diseases. NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency. The therapy focuses on peripheral artery disease (PAD), arteriovenous fistula (AVF) maturation for dialysis, and more.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $46.6M
- Last round: Series Unknown (Apr 2023)
- Website: alucentmedical.com
- Phone: 385-722-2300
Industries & Categories
Biotechnology, Health Care, Medical
Social Profiles
Canonical: https://fsome.com/organization/alucent-biomedical-1145 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.